Detalhe da pesquisa
1.
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.
N Engl J Med
; 386(19): 1793-1803, 2022 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35544387
2.
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
N Engl J Med
; 383(19): 1827-1837, 2020 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32459919
3.
Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus.
Clin Infect Dis
; 73(2): e485-e493, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32668455
4.
Vesatolimod, a Toll-like Receptor 7 Agonist, Induces Immune Activation in Virally Suppressed Adults Living With Human Immunodeficiency Virus-1.
Clin Infect Dis
; 72(11): e815-e824, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33043969
5.
Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019.
Clin Infect Dis
; 73(11): e3996-e4004, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33031500
6.
Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care.
Clin Infect Dis
; 73(11): e4166-e4174, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32706859
7.
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.
Lancet
; 396(10246): 239-254, 2020 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32711800
8.
Ledipasvir-Sofosbuvir for 12 Weeks in Children 3 to <6 Years Old With Chronic Hepatitis C.
Hepatology
; 71(2): 422-430, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31220349
9.
Sofosbuvir and Ribavirin Therapy for Children Aged 3 to <12 Years With Hepatitis C Virus Genotype 2 or 3 Infection.
Hepatology
; 71(1): 31-43, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31222783
10.
Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials.
Clin Infect Dis
; 71(6): 1379-1389, 2020 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31606734
11.
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection.
N Engl J Med
; 376(22): 2134-2146, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28564569
12.
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
JAMA
; 324(11): 1048-1057, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32821939
13.
Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in Egypt.
Gut
; 68(4): 721-728, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29666174
14.
Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals.
Clin Infect Dis
; 69(3): 514-522, 2019 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31220220
15.
Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection.
Gastroenterology
; 154(8): 2111-2121.e8, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29535028
16.
Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis.
Gastroenterology
; 155(4): 1120-1127.e4, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29958855
17.
Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV.
Gastroenterology
; 154(4): 989-997, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29174546
18.
Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir-containing regimen: Results from a retreatment study.
J Viral Hepat
; 26(6): 770-773, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30663168
19.
Deferred treatment with a fixed-dose combination of sofosbuvir-velpatasvir for chronic hepatitis C virus genotype 1, 2, 4 and 6 infection.
J Viral Hepat
; 26(10): 1229-1232, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31216086
20.
Comparison of the efficacy of sofosbuvir plus ribavirin in Chinese patients with genotype 3a or 3b HCV infection.
J Med Virol
; 91(7): 1313-1318, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30861150